|   | |
| Clinical data | |
|---|---|
| Routes of administration | Oral | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C28H38N2O2 | 
| Molar mass | 434.624 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
|   (what is this?)    (verify) | |
SER-601 (COR-167) is a drug which acts as a potent and selective cannabinoid CB2 receptor agonist, based on a quinolone-3-carboxylic acid core structure, with 190 times selectivity for CB2 over the related CB1 receptor. It has analgesic effects in animal studies, as well as neuroprotective effects, [1] but without a "cannabis high" due to its low affinity for CB1. [2] A number of related compounds are known, almost all of which have high selectivity for CB2. [3]